BioSpace News Archive

Transparency Market Research has published a new report on the 3D laparoscopy imaging systems market for the forecast period of 2019–2027.

High incidence of respiratory syncytial virus especially among infants and elderly serves as a significant growth factor for respiratory syncytial virus diagnostics market.

The global respiratory care devices market has been gaining traction in the last few years. A significant rise in the geriatric population is one of the major factors estimated to encourage the growth of the overall market in the next few years.

Allergy to cats and dogs is extremely common and occurs in up to 25% of people with allergies. Cat allergies are twice as common as dog allergies.

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that two HEPLISAV-B abstracts have been selected for oral presentation at the 2021 Annual Conference on Vaccinology Research (ACVR).

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centric and technology-enabled chronic disease management solutions including home healthcare equipment, medical supplies to the home and related services in the United States, announced today that it will release its financial results for the first quarter ended March 31, 2021

Believes Board’s Abject Failure to Exert Sufficient Oversight of Management Has Led to Significant Stockholder Value Destruction and Must Be Immediately Addressed Adverum Is Abusing the Corporate Machinery to Entrench Incumbent Directors and Disenfranchise Stockholders

MorphoSys AG and Incyte announced the first patient has been dosed in the placebo-controlled Phase 3 inMIND study evaluating the efficacy and safety of tafasitamab or placebo in combination with lenalidomide and rituximab in patients with relapsed or refractory follicular lymphoma or marginal zone lymphoma.

Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a non-exclusive license under a subset of Conformis’ U.S. patents for the use of patient-specific instruments with off-the-shelf implants in Paragon 28’s APEX 3D™ Total Ankle Replacement System.

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will co-host a webinar entitled “Overcoming Supply Chain Issues During the COVID-19 Pandemic” with Mawi DNA Technologies at 11 a.m. ET on Wednesday, April 21.